Literature DB >> 23952847

Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.

Geewon Lee1, Kyung Soo Lee, Jung Won Moon, Won-Jung Koh, Byeong-Ho Jeong, Yeon Joo Jeong, Hak Jin Kim, Sookyoung Woo.   

Abstract

RATIONALE: Existing literature is inconclusive regarding how the nodular bronchiectatic form of Mycobacterium avium complex (MAC) disease will progress without treatment and when treatment initiation should be considered.
OBJECTIVES: To assess the natural course of MAC pulmonary disease by serial thin-section computed tomography (CT).
METHODS: Of 339 patients with nodular bronchiectatic form of MAC disease, we selected 265 untreated patients who had serial CTs (mean observation period, 32 ± 21 mo). Two independent chest radiologists reviewed retrospectively all CT scans for the presence and extent of lung abnormalities (maximal total score, 30).
MEASUREMENTS AND MAIN RESULTS: Of 265 patients, 126 patients (48%) had disease that had progressed and that needed treatment owing to radiologic deterioration or worsening symptoms, and the remaining 139 patients (52%) did not. On multivariate analysis, the presence of cavity (adjusted hazard ratio, 2.06; P = 0.004) and consolidation (adjusted hazard ratio, 1.55; P = 0.019) at initial CT remained as independent factors associated with disease progression and treatment requirement. The presence of cavitary lesions demonstrated the highest positive predictive value (61%) and significant correlation (P = 0.005) with smear positivity. Differences in the extent of each pattern and total CT score in the serial studies were significantly larger (P < 0.05) in patients requiring treatment. The total CT score increased by 2.41 in the treatment-requiring group compared with 0.25 in the group that did not receive treatment.
CONCLUSIONS: Without treatment, about half of patients demonstrate progressive disease on serial CT over a mean follow-up period of 32 months and, thus, required treatment. Patients showing cavities or consolidation on initial CT are more likely to have progressive disease and thus to require treatment eventually.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23952847     DOI: 10.1513/AnnalsATS.201303-062OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  25 in total

1.  Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Byung Woo Jhun; Seong Mi Moon; Su-Young Kim; Hye Yun Park; Kyeongman Jeon; O Jung Kwon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Myung Jin Chung; Kyung Soo Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Shannon Novosad; Emily Henkle; Kevin L Winthrop
Journal:  Curr Pulmonol Rep       Date:  2015-07-12

3.  Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Won-Jung Koh; Byeong-Ho Jeong; Kyeongman Jeon; Hye Yun Park; Su-Young Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

4.  A Case of Cavitary Mycobacterium chimaera.

Authors:  Bracha Robinson; Moiuz Chaudhri; Jeffrey A Miskoff
Journal:  Cureus       Date:  2022-07-18

5.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

6.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

7.  Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.

Authors:  Hyung Koo Kang; Hye Yun Park; Dohun Kim; Byeong-Ho Jeong; Kyeongman Jeon; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

8.  Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.

Authors:  Seong Mi Moon; Hye Yun Park; Kyeongman Jeon; Su-Young Kim; Myung Jin Chung; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Won-Jung Koh
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

9.  Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report.

Authors:  Mudit Chowdhary; Umesh Narsinghani; Ritu A Kumar
Journal:  BMC Infect Dis       Date:  2015-07-23       Impact factor: 3.090

Review 10.  Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.

Authors:  Giulia Bonaiti; Alberto Pesci; Almerico Marruchella; Giuseppe Lapadula; Andrea Gori; Stefano Aliberti
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.